Ampersand Capital Partners

Lexington Medical is a medical device company based in Watertown, Massachusetts, founded in 2013. The company specializes in manufacturing minimally invasive surgical stapling solutions designed to simplify various surgical procedures such as cholecystectomy, bariatric surgery, colectomy, appendectomy, and hysterectomy. Lexington Medical's products are intended for healthcare providers, aiming to enhance the efficiency and reliability of surgical operations through innovative design engineering and smart manufacturing processes.

VIVEbiotech specializes in developing and producing lentiviral vectors under EMA and FDA guidelines. These vectors are used to treat various conditions such as blood cancers, solid tumors, and rare diseases. The company offers contract development and manufacturing services tailored to clients' needs, supporting research on lentiviral vectors for rare diseases and hematological cancer testing.

Avid Bioservices is a contract development and manufacturing organization (CDMO) specializing in biopharmaceutical products. It offers a range of services, including clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submissions support. The company focuses on quality and expertise, tailoring its services to meet the unique needs of its clients, primarily pharmaceutical and biotechnology companies. By outsourcing to Avid, these companies can accelerate the development and manufacturing of their biologics, ultimately bringing new therapies to market more efficiently.

Nektar Therapeutics is a biopharmaceutical company based in San Francisco, California, with additional operations in Huntsville, Alabama, and Hyderabad, India. The company focuses on researching and developing investigational drugs for oncology, immunology, and virology, alongside a portfolio of partnered approved medicines. Its clinical pipeline includes notable candidates such as NKTR-181 for chronic low back pain, ONZEALD for advanced metastatic breast cancer, and Bempegaldesleukin, designed to enhance cancer-killing T cell activity. Nektar is also developing therapies for autoimmune diseases, including NKTR-358, and various other conditions like hemophilia A, opioid-induced constipation, and systemic lupus erythematosus. The company's strategy involves leveraging the immune system to combat cancer and restore immune balance in autoimmune disorders. Nektar has established collaboration agreements with several major pharmaceutical companies, enhancing its research capabilities and development efforts. Incorporated in 1990, Nektar Therapeutics continues to advance its innovative drug candidates through various stages of clinical trials.

Biologos, LLC is a manufacturer specializing in sterile filtered and irradiated biological solutions, including sera, enzyme solutions, sterile filtered reagents, balanced salt solutions, and custom formulations. With over 40 years of experience, the company has established itself as a trusted provider of standard and custom cell culture media and reagents, focusing on quick product formulation and distribution. Biologos serves a diverse clientele, including more than 200 U.S.-based tissue banks and leading animal health companies, having shipped over 7 million liters of product globally. The company is dedicated to supporting the advancement of health and wellness through high-quality biological solutions, emphasizing research and development to meet the specific needs of its clients. Founded in 1976, Biologos is headquartered in Montgomery, Illinois.

Specac International specializes in the manufacturing of spectroscopic accessories, primarily serving industries such as forensic science, life sciences, pharmaceuticals, research, and quality control. Founded in 1954, the company has evolved to meet the needs of academic, industrial, and research institutions worldwide by providing innovative and reliable infrared (IR) and Fourier-transform infrared (FTIR) sample handling devices. Its diverse product range includes spectrometers, kits, wire grid polarizers, reflectance and microscopy accessories, transmission windows, and hydraulic presses, catering to various applications in atomic and molecular spectroscopy. With a strong commitment to quality and innovation, Specac has established a global reputation, becoming a trusted partner for spectroscopists seeking advanced solutions in their fields.

Julius Clinical specializes in distinct therapeutic areas that offer a full-service proposal or separate functional service.

ProtaGene is an analytical service provider specializing in the biopharmaceutical sector, particularly in the development of biologic therapeutics and cell and gene therapies. The company offers a comprehensive suite of protein and gene analytic capabilities, catering to the needs of biosimilar developers by facilitating the demonstration of biosimilarity. ProtaGene's services include peptide mapping, protein quantification, protein modification analysis, bioassays, impurity assessment, and detailed characterization of antibodies and related products. These offerings are designed to support clients throughout the product lifecycle, enabling advanced analytics that enhance biopharmaceutical development processes.

Vernal Biosciences is an mRNA manufacturing company that specializes in providing high-purity mRNA for research and clinical applications. The company leverages advanced processing and analytical methods to streamline the manufacturing process, significantly reducing the time and uncertainty typically associated with developing advanced therapeutics. Vernal Biosciences offers its services on a transactional basis, focusing on mRNA and lipid nanoparticle-mRNA (LNP-mRNA) production for use in various research contexts involving cells, animals, and humans. This approach enables research professionals to access on-demand, high-purity mRNA, supporting efficient drug discovery and development while minimizing the need for substantial investments in specialized teams and facilities.

NanoImaging Services, Inc. is a provider of transmission electron microscopy imaging and analysis services, catering to the pharmaceutical, biotechnology, and nanotechnology sectors. Established in 2007 and headquartered in San Diego, California, the company specializes in a range of services including sizing and counting, characterization of sub-micron aggregates, liposomes, emulsions, proteins, and viruses, as well as 3D structure determination. With a strong focus on client collaboration and expertise, NanoImaging Services has developed a reputation for reliability within its field. The company has invested in state-of-the-art facilities equipped with advanced electron microscopes and computational infrastructure, enabling them to support structural biology, nanoparticle characterization, and good manufacturing practices. Through recent expansions, NanoImaging Services has positioned itself as a leading provider of transmission electron microscopy and cryo-electron microscopy services within the industrial life science market, serving clients across North America, Europe, Asia, and beyond.

Iuvo is a contract research organization that provides preclinical testing, clinical research, and consulting services to the healthcare sector.

AcuraBio is a contract development and manufacturing organization that specializes in providing services to the pharmaceutical, biotechnology, and veterinary industries. The company offers a range of biopharmaceutical solutions, including recombinant proteins, vaccines, and complex live biotherapeutic products. AcuraBio is committed to supporting its clients in the development and commercialization of innovative therapeutics by ensuring quality, cost-effectiveness, and strong intellectual property protections. Through its expertise and comprehensive service offerings, AcuraBio plays a vital role in helping clients navigate the complexities of bringing new therapies to market.

Phosphorex is a prominent contract development and manufacturing organization (CDMO) that specializes in sustained release formulations, nanomedicine, and the delivery of nucleic acids. Established in 2005, the company collaborates with the biomedical community to develop a range of microparticles, nanoparticles, and particle-based pharmaceutical formulations. By offering services such as formulation development, feasibility studies, optimization, and process development, Phosphorex helps pharmaceutical and biotechnology companies enhance drug delivery solutions. The focus on optimizing drug release rates, targeting capabilities, and bioavailability aims to assist healthcare professionals in achieving effective therapeutic outcomes while minimizing adverse clinical effects.

Sterling Medical Devices is a custom electro-mechanical and software solution provider for the medical device industry.

AnaBios is a contract research organization (CRO) focused on enhancing drug discovery through human-centric methodologies. The company utilizes proprietary technology that leverages human donor organs and tissues to examine ex vivo human responses to drugs, thereby deepening the understanding of human physiology's molecular and functional aspects. Its research primarily targets significant unmet medical needs, including cardiac disease, pain management, polycystic kidney disease, and neurodegeneration. By generating valuable predictive human data prior to clinical trials, AnaBios aids pharmaceutical companies, contract research organizations, and academic institutions in selecting the most effective and safest drugs, ultimately reducing the time and costs associated with clinical trial failures. Through collaborations with Fortune 500 companies, AnaBios aims to facilitate therapeutic advancements that contribute to improved patient outcomes and wellbeing.

Vernal Biosciences is an mRNA manufacturing company that specializes in providing high-purity mRNA for research and clinical applications. The company leverages advanced processing and analytical methods to streamline the manufacturing process, significantly reducing the time and uncertainty typically associated with developing advanced therapeutics. Vernal Biosciences offers its services on a transactional basis, focusing on mRNA and lipid nanoparticle-mRNA (LNP-mRNA) production for use in various research contexts involving cells, animals, and humans. This approach enables research professionals to access on-demand, high-purity mRNA, supporting efficient drug discovery and development while minimizing the need for substantial investments in specialized teams and facilities.

Syft Technologies Ltd. specializes in the development and marketing of advanced air analysis solutions, primarily through its innovative mass spectrometry technology. The company produces the Voice200 SIFT-MS instrument, which allows for the simultaneous identification and quantification of various gaseous chemicals, including volatile organic compounds (VOCs) at extremely low concentrations. Its product offerings also include a Sample Collection Case for efficient field sampling and a Sample Bag Flushing Station for cleaning sample bags. Syft's analytical solutions cater to diverse sectors such as environmental monitoring, food and fragrance analysis, medical research, and oil and gas exploration. Founded in 2002 and headquartered in Christchurch, New Zealand, Syft Technologies has expanded its presence with additional locations in Warrington, the United Kingdom, and Pittsburgh, Pennsylvania, and distributes its products through a network across several European countries.

BioEcho Life Sciences specializes in the development and production of advanced technologies for molecular biology and diagnostics. The company focuses on manufacturing nucleic acid purification products designed to enhance laboratory workflows in a more convenient, robust, and sustainable manner. Utilizing a proprietary single-step purification technology, BioEcho offers innovative sample lysis and purification tools that facilitate rapid and high-quality extraction of nucleic acids. These tools serve a variety of sectors, including clinical diagnostics, biotechnology, agricultural, and industrial applications. By streamlining DNA and RNA extraction processes, BioEcho aims to improve efficiency compared to traditional methods, while also reducing inhibitors that can affect downstream PCR and sequencing applications.

ProtaGene is an analytical service provider specializing in the biopharmaceutical sector, particularly in the development of biologic therapeutics and cell and gene therapies. The company offers a comprehensive suite of protein and gene analytic capabilities, catering to the needs of biosimilar developers by facilitating the demonstration of biosimilarity. ProtaGene's services include peptide mapping, protein quantification, protein modification analysis, bioassays, impurity assessment, and detailed characterization of antibodies and related products. These offerings are designed to support clients throughout the product lifecycle, enabling advanced analytics that enhance biopharmaceutical development processes.

Magritek Limited is a New Zealand-based company that specializes in the design and manufacture of advanced instruments for nuclear magnetic resonance (NMR) and magnetic resonance imaging (MRI). Founded in 2004, the company offers a range of products, including ultra-compact spectrometers, rock core analyzers, and portable NMR sensors, catering to various sectors such as oil and gas, pharmaceuticals, and education. Their innovative solutions are cryogen-free and compact, making them suitable for benchtop use in laboratories. Magritek’s offerings also include specialized software for processing NMR data and systems designed for hands-on learning applications. The company serves a global market through a network of distributors, with additional operational presence in Aachen, Germany.

Arranta Bio LLC is a contract development and manufacturing organization specializing in the development and production of live biopharmaceutical products, particularly those targeting human microbiome-related diseases. Founded in 2019 and headquartered in Watertown, Massachusetts, the company offers a comprehensive range of services, including media formulation, cell banking, fermentation, lyophilization, and analytical services, all conducted under current Good Manufacturing Practices (cGMP). Arranta Bio operates a process development and cGMP manufacturing facility in Gainesville, Florida, where it focuses on bacterial fermentation, isolation, drying, and encapsulation processes for live biotherapeutic products. The company aims to support innovators in the healthcare sector in bringing effective treatments to market through its advanced manufacturing capabilities.

GeneWerk GmbH is a specialized testing laboratory based in Heidelberg, Germany, that focuses on cell and gene therapy. Founded in 2014 by a team of experts, the company offers a range of services for preclinical and clinical trial patient sample analysis. Its product offerings include integration site analysis of viral vectors, AAV vector quality control, immune repertoire analysis, and gene editing on- and off-target analyses, along with advanced bioinformatics support for next-generation sequencing (NGS). GeneWerk operates in compliance with regulatory guidance from the U.S. Food and Drug Administration and the European Medicines Agency, providing crucial testing services to sponsors in the cell and gene therapy sectors. The company's innovative approach is supported by the expertise of its founders and a commitment to developing new analytical methods tailored to the needs of its clients.

ALPCO Diagnostics is a manufacturer specializing in immunoassay-based products aimed at supporting both life science research and clinical diagnostics. The company develops a diverse range of specialty immunoassay products, including In Vitro Diagnostics (IVDs) and Research Use Only (RUO) assays. These products are designed to aid in the investigation, detection, diagnosis, and treatment of various health-related disorders and diseases. By providing scientists and healthcare professionals with essential testing solutions, ALPCO Diagnostics contributes to the advancement of research and enhances the quality of patient care.

Interpace Biosciences is a leader in the life sciences sector, specializing in complex molecular analysis to facilitate the early diagnosis and treatment of cancer. The company operates through its Interpace Diagnostics business unit, which offers clinically beneficial molecular diagnostic tests and pathology services. Among its notable products are PancraGen, ThyGeNext, ThyraMir, RespriDX, and BarreGen, all designed to evaluate cancer risk and guide personalized treatment strategies. Interpace Biosciences utilizes advanced technology in personalized medicine, focusing on genomic tests aimed at early detection for patients with indeterminate biopsy results or those at high risk for cancer. Through its comprehensive approach, the company plays a critical role in enhancing patient diagnosis and management in oncology.

Arranta Bio LLC is a contract development and manufacturing organization specializing in the development and production of live biopharmaceutical products, particularly those targeting human microbiome-related diseases. Founded in 2019 and headquartered in Watertown, Massachusetts, the company offers a comprehensive range of services, including media formulation, cell banking, fermentation, lyophilization, and analytical services, all conducted under current Good Manufacturing Practices (cGMP). Arranta Bio operates a process development and cGMP manufacturing facility in Gainesville, Florida, where it focuses on bacterial fermentation, isolation, drying, and encapsulation processes for live biotherapeutic products. The company aims to support innovators in the healthcare sector in bringing effective treatments to market through its advanced manufacturing capabilities.

New England Peptide, Inc. specializes in the design and manufacture of a wide range of peptides and related products. Its offerings include bioactive peptides, amino acids, phospho amino acids, pseudoprolines, and heavy amino acids, as well as peptide synthesis accessories and stable isotope standard tryptic peptides for protein identification. The company also provides custom polyclonal and monoclonal antibodies, along with analytical services such as amino acid analysis, liquid chromatography/mass spectrometry, sequencing, and sample preparation. Catering primarily to organizations involved in drug and vaccine discovery, New England Peptide sells products online and through distributors in Japan, Taiwan, and Korea. Founded in 1998 and headquartered in Harvard, Massachusetts, the company maintains an additional office in Cambridge, Massachusetts.

Vivitide is a biotechnology company that specializes in the production and customization of antibodies and peptides for various industries. They offer peptide arrays, catalog peptides, novel amino acids, derivatives, small molecule synthesis, and resins tailored to meet clients' needs in drug, vaccine, and diagnostic development. Their products are designed to address diverse health challenges such as cancer, diabetes, obesity, infections, and HIV.

Interpace Biosciences is a leader in the life sciences sector, specializing in complex molecular analysis to facilitate the early diagnosis and treatment of cancer. The company operates through its Interpace Diagnostics business unit, which offers clinically beneficial molecular diagnostic tests and pathology services. Among its notable products are PancraGen, ThyGeNext, ThyraMir, RespriDX, and BarreGen, all designed to evaluate cancer risk and guide personalized treatment strategies. Interpace Biosciences utilizes advanced technology in personalized medicine, focusing on genomic tests aimed at early detection for patients with indeterminate biopsy results or those at high risk for cancer. Through its comprehensive approach, the company plays a critical role in enhancing patient diagnosis and management in oncology.

N2 Biomedical specializes in providing coating, anodizing, and printing services for medical devices, including guidewires, core wires, hypo tubes, and forming mandrels. The company serves the global healthcare and medical device sectors, offering a comprehensive range of services from initial concept development to commercialization. N2 Biomedical collaborates closely with clients to deliver flexible prototype work and high-volume production capabilities. Its expertise extends to enhancing the material characteristics of implantable and other medical devices across various applications, particularly in orthopedic and cardiovascular markets. The company's surface treatment solutions aim to improve properties such as wear and fretting resistance, corrosion resistance, fracture toughness, lubricity, infection resistance, biocompatibility, aesthetics, and radiopacity.

Vibalogics GmbH is a contract development and manufacturing organization (CDMO) specializing in complex live biological products. Founded in 2002 and based in Cuxhaven, Germany, the company offers a range of services, including process development, manufacturing, and fill and finish operations, tailored for biopharmaceutical companies focused on oncolytic viral therapies, gene therapies, and vaccines. Vibalogics provides essential support for its clients, which include pharmaceutical companies, biotechnology firms, and academic institutions, across Europe, the United States, and the Asia-Pacific region. The company also offers specialized services such as cell and virus banking, drug production, quality control release, and stability testing, ensuring comprehensive support for both clinical and commercial needs. Vibalogics was previously known as Bioprotect Research GmbH until its rebranding in 2007.

Genome Diagnostics B.V., operating as GenDx, is a biotechnology company based in Utrecht, the Netherlands, specializing in the development and marketing of in vitro diagnostic tests and related services for transplantation. Founded in 2005, GenDx is a pioneer in Sequencing-Based Typing (SBT), providing high-resolution HLA typing products that utilize both Sanger and next-generation sequencing (NGS) techniques. Its product portfolio includes SBTexcellerator, SBTengine, and NGSengine, which facilitate accurate analysis of HLA loci, as well as high-throughput reagents and software solutions for diverse laboratory needs. In addition to its diagnostic products, GenDx offers educational courses and laboratory services, and collaborates with industry partners to enhance its offerings. The company distributes its products both directly and through specialized distributors, affirming its commitment to advancing transplantation diagnostics.

Canopy Biosciences, founded in 2016 and headquartered in St. Louis, Missouri, is a biotechnology company specializing in research tools for genetic engineering, molecular biology, and personalized medicine. The company offers a comprehensive range of products and services designed to facilitate gene editing, gene expression analysis, and bioprocessing. One of its key technologies, TUNR, targets translation elongation by inserting polyA tracks into specific coding regions of the genome, effectively reducing mRNA levels and suppressing protein expression. This innovative approach supports biomedical researchers at universities, research institutions, and within the biotechnology and pharmaceutical sectors, accelerating scientific discovery and enhancing the field of genetic engineering. Canopy Biosciences operates as a subsidiary of Bruker Corporation.

NEOMED-LABS is a provider of clinical immunology laboratory services for biologics drug development. NEOMED-LABS is an independent, pure player in the immunology field whose team of experts and state of the art BSL2 labs were instrumental in the development, qualification, and validation of more than 30 assays supporting the FDA filing of 10 marketed vaccines whose cumulative sales is around $3bn. Our unrivaled expertise in immunotools engineering and stability testing, as well as our capacity of 200k results per year on our immunochemistry, virology, and bacteriology automated platforms are devoted to personalized services and fast track method validation.

MedPharm Ltd., established in 1999, is a leading global provider of pharmaceutical research and development services, specializing in topical and transdermal products. Based in Guildford, UK, with a U.S. office in Durham, North Carolina, the company offers expertise in dermatological, nail, eye, airway, mucosal membrane, and transdermal product development. MedPharm's services encompass formulation development, performance testing, and analytical services, utilizing proprietary models to reduce risk and accelerate development times for both generic and proprietary pharmaceutical customers. The company's expertise is recognized by regulators and investors, with established Centres of Excellence in both the UK and the U.S.

Nexcelom Bioscience LLC is a biotechnology company specializing in the development and marketing of image cytometry products for cell analysis utilized in life sciences and biomedical research. Founded in 2003 and based in Lawrence, Massachusetts, the company offers a range of products, including the Cellometer, which facilitates the counting and analysis of cell lines and primary cells through both bright field and fluorescence imaging, and the Celigo system, known for its high image quality and throughput capabilities for analyzing adherent and suspension cells in microwell plates. Nexcelom also provides a variety of fluorescent reagents and kits tailored for cell counting and cell-based assays, serving diverse research areas such as immuno-oncology, cell therapy, drug discovery, vaccine development, and therapeutic cell line generation.

Detector Technology, Inc. is a prominent manufacturer of products and systems tailored for OEM and equipment manufacturers. Specializing in Channel Electron Multipliers, Glass Extrusion & Fabrication, and Motion Control Products, DeTech operates a cutting-edge fabrication and production facility. With a focus on delivering manufacturing excellence and ensuring customer satisfaction, Detector Technology has built a strong reputation over the past two decades as a trusted provider in the industry.

Adaptas Solutions is a strategic original equipment manufacturer (OEM) that specializes in providing contract manufacturing services for analytical and laboratory equipment. The company focuses on developing critical components and subsystems for gas chromatography, mass spectrometry, and liquid chromatography applications. Its product offerings include electron multipliers, filaments, power supplies, and ion optic grids, as well as components for liquid handling and lab automation. By supplying high-quality products, Adaptas Solutions enables manufacturers of analytical and laboratory equipment to enhance their production processes and meet the demands of their respective markets.

LakePharma is a contract research organization (CRO) based in the San Francisco Bay Area that provides a comprehensive suite of biologics services aimed at the pharmaceutical and biotechnology industries. The company specializes in antibody and protein engineering, cell line development, and protein production, offering end-to-end solutions that encompass antibody discovery, molecular engineering, protein chemistry, bioexpression, biofunction, bioprocessing, and bioanalytics. LakePharma employs in-house technology platforms to deliver high-quality, cost-effective services, with a focus on efficiency in both small and large-scale production processes. Each project is managed by a dedicated study director to ensure timely and transparent communication, while clients can access real-time project data through a secure cloud-based portal. LakePharma adheres to Good Laboratory Practices (GLP) to maintain the quality and integrity of study data, and it can operate in compliance with FDA documentation requirements for nonclinical laboratory studies. All services are offered on a fee-for-service basis, ensuring a straightforward and royalty-free engagement model for clients.

Corpus Medical is a specialized firm that provides consulting services for the medical device industry. The company excels in designing, developing, and manufacturing advanced technology catheters for various markets, including electrophysiology, peripheral vascular, and cardiovascular sectors. Corpus Medical's expertise spans the entire product lifecycle, from concept to market, offering contract development and manufacturing services. These services are tailored to help customers efficiently develop and commercialize innovative interventional medical devices, catheter-based delivery systems, and implants.

Canopy Biosciences, founded in 2016 and headquartered in St. Louis, Missouri, is a biotechnology company specializing in research tools for genetic engineering, molecular biology, and personalized medicine. The company offers a comprehensive range of products and services designed to facilitate gene editing, gene expression analysis, and bioprocessing. One of its key technologies, TUNR, targets translation elongation by inserting polyA tracks into specific coding regions of the genome, effectively reducing mRNA levels and suppressing protein expression. This innovative approach supports biomedical researchers at universities, research institutions, and within the biotechnology and pharmaceutical sectors, accelerating scientific discovery and enhancing the field of genetic engineering. Canopy Biosciences operates as a subsidiary of Bruker Corporation.

Canopy Biosciences, founded in 2016 and headquartered in St. Louis, Missouri, is a biotechnology company specializing in research tools for genetic engineering, molecular biology, and personalized medicine. The company offers a comprehensive range of products and services designed to facilitate gene editing, gene expression analysis, and bioprocessing. One of its key technologies, TUNR, targets translation elongation by inserting polyA tracks into specific coding regions of the genome, effectively reducing mRNA levels and suppressing protein expression. This innovative approach supports biomedical researchers at universities, research institutions, and within the biotechnology and pharmaceutical sectors, accelerating scientific discovery and enhancing the field of genetic engineering. Canopy Biosciences operates as a subsidiary of Bruker Corporation.

Brammer Bio, LLC specializes in the development and manufacturing of cell and gene therapies for the pharmaceutical and biotechnology sectors. The company provides a range of services, including pre-clinical process and analytical development, process optimization, and clinical and commercial supply of drug substances and formulated products. Brammer Bio focuses on supporting the production of autologous and allogeneic cell therapies, as well as viral vector products for therapeutic applications. With facilities in Alachua, Florida, and plans for a new site in Lexington, Massachusetts, the company aims to enhance its capacity for large-scale manufacturing and clinical support. As a contract development and manufacturing organization, Brammer Bio collaborates with biopharma clients to facilitate the delivery of innovative therapies, ensuring regulatory compliance and accelerating the commercialization of novel medicines.

Avista Pharma Solutions is a contract testing, development, and manufacturing organization that operates across three locations in Agawam, Massachusetts; Durham, North Carolina; and Longmont, Colorado. The company provides a wide range of services to clients in the pharmaceutical, animal health, and medical device sectors. These services include early drug development, active pharmaceutical ingredient (API) and drug product development, as well as compliant Good Manufacturing Practice (cGMP) manufacturing. Additionally, Avista offers standalone analytical and microbiology testing support, facilitating the development of newly created medicinal drugs. With over 200,000 square feet of laboratory and manufacturing space, Avista Pharma Solutions plays a vital role in the lifecycle of drug development and testing.

Gyros Protein Technologies AB is a Swedish company specializing in solutions for peptide synthesis and bioanalysis, aimed at enhancing biomolecule performance and productivity in various scientific fields. Founded in 2016 and headquartered in Uppsala, the company offers a range of peptide synthesizer platforms, including PurePep Chorus, Tribute, Prelude X, Symphony X, and Sonata, which provide high purity and flexibility for the synthesis of peptides. Additionally, Gyros Protein Technologies develops proprietary nanoliter-scale immunoassay platforms, such as Gyrolab xPand and Gyrolab xP workstation, utilized by professionals in pharmaceutical, biotechnology, contract research, and contract manufacturing sectors for bioanalytical applications. These technologies support critical processes such as pharmacokinetics, immunogenicity assessments, and the quantification of bioprocess-related impurities. By offering advanced tools for peptide synthesis and bioanalysis, Gyros Protein Technologies accelerates the discovery, development, and manufacturing of biotherapeutics. It operates as a subsidiary of Mesa Laboratories, Inc.

GENEWIZ, Inc. is a global contract research organization specializing in genomics and DNA sequencing services. Founded in 1999 and headquartered in South Plainfield, New Jersey, the company serves a diverse clientele, including pharmaceutical, biotechnology, academic, agricultural, clinical, and government institutions. GENEWIZ offers a comprehensive range of services, including Sanger DNA sequencing, gene synthesis, molecular biology techniques, genomic mutation analysis, and bioinformatics, all designed to enhance research productivity and efficiency. The company is also equipped to provide regulatory-compliant laboratory services for FDA applications, including RNA/DNA identity studies and SNP testing. With a focus on delivering high-quality data and exceptional technical support, GENEWIZ is committed to accelerating scientific discovery and advancing translational medicine. The company operates multiple locations across the United States and internationally in China, the United Kingdom, France, Germany, and Japan, solidifying its position as a preferred partner in the life sciences sector. As of November 2018, GENEWIZ operates as a subsidiary of Brooks Automation, Inc.

Azurity Pharmaceuticals is a pharmaceutical company dedicated to developing and marketing drug products that cater to patients with unmet medical needs. The company focuses on creating innovative medicines for various conditions, including attention deficit hyperactivity disorder (ADHD), hypertension, and congestive heart failure. A significant emphasis is placed on developing and commercializing oral liquid medications, which are particularly beneficial for children, elderly patients, and others who may struggle to swallow pills or tablets. In addition to these areas, Azurity also produces medications like antimicrobial agents and mouthwashes, enhancing the ability of pharmacists to provide better alternatives to traditionally compounded medications.

Elite One Source Nutritional Services, Inc., established in 2013 and headquartered in Missoula, Montana, specializes in contract manufacturing services for nutritional and dietary supplements. The company operates as a subsidiary of DCC Health & Beauty Solutions Limited. Through its manufacturing capabilities, Elite One Source caters to businesses seeking to produce high-quality dietary products, ensuring compliance with industry standards and regulations.

NutraMed, Inc. is a Chino, California-based company that specializes in the development, manufacturing, and marketing of nutritional supplement products. Founded in 1998, NutraMed offers a diverse range of products, including tablets, capsules, and powders, catering to customers both in the United States and internationally. The company provides various manufacturing services, such as blending, granulation, tableting, and the creation of timed release formulations. Additionally, NutraMed produces bilayer tablets, offers multiple types of tablet coatings, and specializes in two-piece hard-shell encapsulation. Their capabilities also extend to packaging solutions, including stick-packs, multi-packs, blister cards, and powder packaging, as well as enteric coating for tablets, capsules, and soft gels.

Sanova Dermatology, PLLC is a comprehensive dermatology center located in Austin, Texas, specializing in both cosmetic and medical dermatology services. The company provides a wide range of treatments, including wrinkle reduction, acne management, psoriasis care, and skin cancer treatment. Its offerings encompass general dermatology, surgical dermatology, and aesthetic procedures such as Mohs micrographic surgery, dermal fillers, and Botox. Sanova Dermatology aims to deliver individualized skin-care solutions tailored to the unique needs of its patients, ensuring professional care and a commitment to high-quality dermatological services.

Willow Laboratories specializes in cannabis packaging solutions, offering custom packaging for craft cannabis products alongside extract and formulation services. Additionally, they provide clinical and forensic toxicology laboratory services, focusing on urine, hair, and saliva drug testing for various healthcare providers such as treatment centers and physician practices.

Bioventus LLC is a medical technology company specializing in orthobiologic solutions aimed at enhancing bone healing and managing osteoarthritis. The company offers a range of products, including active healing therapies that support the recovery of bone fractures and alleviate chronic pain associated with osteoarthritis. Its portfolio features injection therapies for osteoarthritic joints, surgical orthobiologics, and bone healing solutions that promote the body’s natural healing processes. Key offerings include the EXOGEN Ultrasound Bone Healing System and various joint fluid therapies. Bioventus is recognized for its innovative and effective products, which adhere to high quality standards and evidence-based practices. Headquartered in Durham, North Carolina, Bioventus employs around 500 people and generates approximately $240 million in annual revenue. The company operates a distribution network to make its products available to healthcare providers. Bioventus was established in 2011, evolving from the Biologics Division of Smith & Nephew.

CoreLab Partners is a biotech company that provides services related to cardio health monitoring and also provides technological support.

Nitinol Devices & Components (NDC), based in Fremont, California, is a privately held medical device company specializing in Nitinol technology. The company offers comprehensive services in manufacturing, research, development, and regulatory support, focusing on the medical sector. NDC is dedicated to advancing its capabilities to address the increasing demand for its shape-memory and superelastic Nitinol products, which are essential in various medical applications. Through its commitment to innovation and quality, NDC plays a significant role in the evolving landscape of medical devices.

Blue Sky Biotech, Inc. is a preclinical Contract Research Organization (CRO) based in Worcester, Massachusetts, specializing in pharmaceutical research and development. The company provides essential services in gene cloning, protein expression, purification, and assay development, catering to the needs of major pharmaceutical companies. By alleviating labor-intensive tasks, Blue Sky enables scientists to focus on critical experimentation and innovative research. With a commitment to enhancing productivity in early discovery biology processes, Blue Sky Biotech plays a vital role in improving the efficiency of the drug discovery process, ultimately contributing to advancements in healthcare and the promotion of longer, healthier lifespans for individuals.

FirstRain, Inc. is a developer of a cloud-based business analytics platform headquartered in San Mateo, California, with additional offices in New York and Gurgaon, India. Founded in 2000, the company focuses on transforming how businesses make decisions by utilizing its advanced analytics technology to capture and analyze vast amounts of unstructured data from the web and social media. This platform is tailored for sales, marketing, and finance professionals, enabling them to identify new sales opportunities, generate leads, and assess business risks effectively. FirstRain's solutions are designed to integrate seamlessly with leading CRM and social enterprise platforms, enhancing the decision-making process for Fortune 1000 companies by providing insights that are aligned with their specific strategies and market needs. As of July 2017, FirstRain operates as a subsidiary of Ignite Technologies, Inc.

Bako Integrated Physician Solutions is the premier provider of diagnostic and therapeutic services focusing on the skin, soft tissue and bone of the lower extremity. Their pathology team provides not just information, but also intelligence to enable better patient care.

Signature Genomic Laboratories is a Spokane, Washington-based provider of molecular cytogenetic diagnostic services. The company specializes in a range of diagnostic offerings, including pediatric and adult testing, as well as prenatal services. It employs advanced techniques such as FISH analysis for clinically relevant loci and provides comprehensive prenatal diagnosis services. Additionally, Signature Genomic Laboratories offers interpretation of genome microarrays and G-banded karyotype analysis, catering to the needs of healthcare professionals and patients seeking precise genetic insights.

FirstRain, Inc. is a developer of a cloud-based business analytics platform headquartered in San Mateo, California, with additional offices in New York and Gurgaon, India. Founded in 2000, the company focuses on transforming how businesses make decisions by utilizing its advanced analytics technology to capture and analyze vast amounts of unstructured data from the web and social media. This platform is tailored for sales, marketing, and finance professionals, enabling them to identify new sales opportunities, generate leads, and assess business risks effectively. FirstRain's solutions are designed to integrate seamlessly with leading CRM and social enterprise platforms, enhancing the decision-making process for Fortune 1000 companies by providing insights that are aligned with their specific strategies and market needs. As of July 2017, FirstRain operates as a subsidiary of Ignite Technologies, Inc.

Agilux Laboratories, Inc. is a contract research organization based in Worcester, Massachusetts, founded in 2007. The company specializes in supporting drug discovery, pre-clinical, and clinical research for the biotech and pharmaceutical industries. Agilux offers a comprehensive suite of services that includes drug metabolism and pharmacokinetic (DMPK) services, discovery bioanalytical, GLP bioanalytical, in vivo, in vitro, and immunoassay services. By focusing on bioanalytical and pharmacokinetic/pharmacodynamic (PK/PD) testing, Agilux Laboratories aims to provide integrated support for its clients throughout the drug development process.

RadPharm provides radiopharmaceutical products to medical practices in Australia. Its product portfolio includes sterile vials, cold kits, contract manufacturing, and more.

ChanTest specializes in ion channel testing services, offering a comprehensive library of validated human ion channel-expressing cell lines tailored for the pharmaceutical and biotech sectors. The company provides a range of services, including functional screens to profile drug candidates and assess their performance during the drug discovery process. Additionally, ChanTest offers in vitro Good Laboratory Practice (GLP) service products focused on cardiac risk assessment. By collaborating closely with clients, ChanTest aims to expedite the drug development process, ultimately contributing to the creation of safer and more effective medications.

Cequent Pharmaceuticals is an early-stage biopharmaceutical company based in Cambridge, Massachusetts, specializing in the development of RNA interference (RNAi) therapies to prevent and treat various human diseases, including inflammatory conditions and cancer. Founded in 2006, Cequent is pioneering innovative therapeutics utilizing its proprietary TransKingdom RNA interference (tkRNAi) technology, which safely and effectively deactivates specific disease-causing genes. This technology employs non-pathogenic bacteria to produce and deliver RNAi directly into cells. Currently, Cequent's leading drug candidates are in pre-clinical development, specifically targeting colon cancer prevention and inflammatory bowel disease. The company's scientific foundation is rooted in significant research conducted at the Institut Pasteur in Paris and the Beth Israel Deaconess Medical Center/Harvard Medical School.

CRI Lifetree operates as a specialized research organization. The Company focuses on the conduct and design of early stage endocrinology and infectious disease research products and services. CRI Lifetree provides clinical research throughout the United States.

Magellan Diagnostics is a medical device company specializing in the development and manufacture of point-of-care systems, clinical laboratory instruments, and analytical laboratory services focused on lead testing. Based in North Billerica, Massachusetts, the company offers products such as LeadCare II for blood lead testing, LeadCare Ultra for laboratory use, and LeadCare Plus for smaller volume laboratories. Magellan Diagnostics also provides various analytical services, including monitoring exposure to lead and heavy metals. The company's mission is to identify and protect individuals at risk of lead poisoning, a preventable health threat. Founded in 2004 as Magellan Biosciences, Inc., the company has roots tracing back to the late 1960s when it was originally established as ESA, Inc. by MIT graduates.

FirstRain, Inc. is a developer of a cloud-based business analytics platform headquartered in San Mateo, California, with additional offices in New York and Gurgaon, India. Founded in 2000, the company focuses on transforming how businesses make decisions by utilizing its advanced analytics technology to capture and analyze vast amounts of unstructured data from the web and social media. This platform is tailored for sales, marketing, and finance professionals, enabling them to identify new sales opportunities, generate leads, and assess business risks effectively. FirstRain's solutions are designed to integrate seamlessly with leading CRM and social enterprise platforms, enhancing the decision-making process for Fortune 1000 companies by providing insights that are aligned with their specific strategies and market needs. As of July 2017, FirstRain operates as a subsidiary of Ignite Technologies, Inc.

Ortho Organizers, a full-line manufacturer and distributor of orthodontics products.

RadPharm provides radiopharmaceutical products to medical practices in Australia. Its product portfolio includes sterile vials, cold kits, contract manufacturing, and more.

Assay Designs, founded in 1992, provides quality, rapid, and easy-to-use products for the worldwide biomedical, pharmaceutical and scientific research communities to "Simplify Your Science®". Thier rapidly expanding product line includes kits and materials for the detection and quantification of molecules that are important in cell regulation, signal transduction, inflammation, oxidative processes and apoptosis. Assay Designs develops, produces and markets CORRELATE™ and TITERZYME® immunoassay kits, detection kits, FLASHLIGHT® and BIOLIGHT™ luminescent compounds, antibodies and miscellaneous compounds. Providing unsurpassed precision and reproducibility, Assay Designs offers a broad range of eicosanoid kits and human and mouse cytokine kits and the world's only non-radioactive COX activity kit. In addition, a wide selection of related antigen and antibody products are available to meet your specific research needs. Assay Designs also offers contract manufacturing and custom design products for specialized research needs.

Medifacts International, Inc. is a provider of cardiovascular safety monitoring services focused on the pharmaceutical and biotech sectors. Founded in 1985 and headquartered in Rockville, Maryland, with additional offices in Germany and China, the company specializes in a range of services including electrocardiogram (ECG) testing, digital Holter monitoring, ambulatory blood pressure monitoring, and telemedicine. Additionally, Medifacts offers consulting and medical writing services, which encompass program and protocol design, statistical analysis, regulatory guidance, and digital data collection and analysis. The company's expertise extends to glucose monitoring and pulmonary services, as well as the management and assessment of medical imaging. Medifacts was acquired by CoreLab Partners in 2010, further enhancing its capabilities and reach within the industry.

ProGene Biomedical is a clinical reference laboratory specializing in clinical immunology and allergy testing.

Endeca Technologies is a provider of information management software that specializes in enterprise search solutions for large organizations, including notable clients such as Borders, Boeing, the Census Bureau, the EPA, Ford, Hallmark, IBM, and Toshiba. The company focuses on guided search technology, which auto-categorizes search results based on user-entered keywords, facilitating more efficient information retrieval. Endeca's pricing for installations ranges significantly, from $100,000 to over $10 million, reflecting the scale and complexity of their solutions. In the competitive landscape, Endeca faces competition from other search technology providers, including FAST Search & Transfer, which was acquired by Microsoft in 2008. Through its innovative software, Endeca aims to help businesses adapt to changing needs and integrate data effectively.

ESA Bioscience is a company that was acquired by Ampersand Capital Partners in 2004.

Panacos Pharmaceuticals, Inc. is a biotechnology company focused on the discovery and development of small-molecule oral drugs aimed at treating human immunodeficiency virus (HIV) and other viral diseases. Established in 1999 and based in Watertown, Massachusetts, the company utilizes innovative technologies to target specific stages in the viral life cycle, such as virus maturation and fusion. Its product pipeline includes advanced programs centered on HIV maturation inhibition, representing the company's commitment to developing next-generation anti-infective therapies.

Proficiency, Inc. specializes in product knowledge integration and CAD interoperability solutions aimed at facilitating data sharing between manufacturers and suppliers across various engineering and manufacturing environments. Founded in 1998 and based in Marlborough, Massachusetts, the company offers a range of services, including product knowledge migration and supplier delivery solutions tailored for original equipment manufacturers and higher-tier suppliers. Its key products include Collaboration Gateway V7.0, which enables seamless transfer of product knowledge among different CAD systems, and Completion Wizard, designed for an interactive completion process. Proficiency also provides CAD translation services, consulting on migration strategies and process integration, as well as implementation services that encompass training and customer support. The company primarily serves clients in the automotive, aerospace and defense, and heavy machinery sectors. As of July 2009, Proficiency operates as a subsidiary of ITI TranscenData.

LightPointe Communications, Inc. (a.k.a. LightPointe Wireless) is privately held. The company was launched in 1998 and is headquartered in San Diego, CA, with regional offices/presence in Europe (Germany & France) and Asia (Thailand). LightPointe also provides solutions via its AirePointe Security & Government Solutions Division (www.AirePointe.com). LightPointe is the number one manufacturer in the world of point-to-point Gigabit Ethernet Free Space Optics and Hybrid Optical-Radio Bridges, and manufactures a complete line of 4G/LTE backhaul radios (60 GHz & 70/80 GHz e-band) for telecom carriers and enterprises such as businesses, schools, the military & government agencies. With over $80 million in product development and over eight key patents, LightPointe has deployed thousands of Gigabit Ethernet bridges and digital video/security backhaul solutions worldwide.

Silicon Wave is a San Diego-based company that specializes in Bluetooth wireless technology. It is recognized as a pioneer in this field and focuses on the design, development, and manufacturing of radio frequency integrated circuits. The company produces RF systems-on-chip that are utilized in various wireless and broadband communication applications. Through its innovative solutions, Silicon Wave contributes significantly to advancements in wireless communication technology.

FirstRain, Inc. is a developer of a cloud-based business analytics platform headquartered in San Mateo, California, with additional offices in New York and Gurgaon, India. Founded in 2000, the company focuses on transforming how businesses make decisions by utilizing its advanced analytics technology to capture and analyze vast amounts of unstructured data from the web and social media. This platform is tailored for sales, marketing, and finance professionals, enabling them to identify new sales opportunities, generate leads, and assess business risks effectively. FirstRain's solutions are designed to integrate seamlessly with leading CRM and social enterprise platforms, enhancing the decision-making process for Fortune 1000 companies by providing insights that are aligned with their specific strategies and market needs. As of July 2017, FirstRain operates as a subsidiary of Ignite Technologies, Inc.

Silicon Wave is a San Diego-based company that specializes in Bluetooth wireless technology. It is recognized as a pioneer in this field and focuses on the design, development, and manufacturing of radio frequency integrated circuits. The company produces RF systems-on-chip that are utilized in various wireless and broadband communication applications. Through its innovative solutions, Silicon Wave contributes significantly to advancements in wireless communication technology.

Viadux, based in Carole Park, Australia, is a subsidiary of Reece Limited. It specializes in providing in-building broadband access solutions to the telecommunications and cable industries, focusing on small-to-medium enterprises and residential customers in multi-tenant units. The company offers a range of pipeline products and services, including ductile iron pipes, valves, and fittings, catering to municipal, commercial, and industrial customers across the Asia Pacific region.

Endeca Technologies is a provider of information management software that specializes in enterprise search solutions for large organizations, including notable clients such as Borders, Boeing, the Census Bureau, the EPA, Ford, Hallmark, IBM, and Toshiba. The company focuses on guided search technology, which auto-categorizes search results based on user-entered keywords, facilitating more efficient information retrieval. Endeca's pricing for installations ranges significantly, from $100,000 to over $10 million, reflecting the scale and complexity of their solutions. In the competitive landscape, Endeca faces competition from other search technology providers, including FAST Search & Transfer, which was acquired by Microsoft in 2008. Through its innovative software, Endeca aims to help businesses adapt to changing needs and integrate data effectively.

Ensemble Communications is a develops wireless infrastructure equipment for high-speed local broadband access applications.

Cyclis Pharmaceuticals is a biopharmaceutical company focused on the research and development of small-molecule drugs aimed at treating cancer. The company utilizes a novel technology that selectively targets and kills cancer cells while preserving healthy cells. This approach works by restoring and activating cellular checkpoints that are often defective in cancer cells. By developing these innovative small-molecule therapies, Cyclis Pharmaceuticals aims to enhance treatment efficacy and minimize toxicity compared to traditional cancer therapies.

Endeca Technologies is a provider of information management software that specializes in enterprise search solutions for large organizations, including notable clients such as Borders, Boeing, the Census Bureau, the EPA, Ford, Hallmark, IBM, and Toshiba. The company focuses on guided search technology, which auto-categorizes search results based on user-entered keywords, facilitating more efficient information retrieval. Endeca's pricing for installations ranges significantly, from $100,000 to over $10 million, reflecting the scale and complexity of their solutions. In the competitive landscape, Endeca faces competition from other search technology providers, including FAST Search & Transfer, which was acquired by Microsoft in 2008. Through its innovative software, Endeca aims to help businesses adapt to changing needs and integrate data effectively.

LightPointe Communications, Inc. (a.k.a. LightPointe Wireless) is privately held. The company was launched in 1998 and is headquartered in San Diego, CA, with regional offices/presence in Europe (Germany & France) and Asia (Thailand). LightPointe also provides solutions via its AirePointe Security & Government Solutions Division (www.AirePointe.com). LightPointe is the number one manufacturer in the world of point-to-point Gigabit Ethernet Free Space Optics and Hybrid Optical-Radio Bridges, and manufactures a complete line of 4G/LTE backhaul radios (60 GHz & 70/80 GHz e-band) for telecom carriers and enterprises such as businesses, schools, the military & government agencies. With over $80 million in product development and over eight key patents, LightPointe has deployed thousands of Gigabit Ethernet bridges and digital video/security backhaul solutions worldwide.

Blackstone Technology Group provides software and services that create high throughput computing environments. Blackstone helps customers speed time-to-market by designing and optimizing infrastructures for high user productivity, low administrative burden, and low ownership cost. Blackstone accomplishes these goals with Consultants who have expertise in the applications and process methodologies, as well as in the design and optimization of large-scale, high-throughput computing environments; and Software products that simplify usage and administration of the environment, as well as maximize computing throughput and architecture scalability.

LightPointe Communications, Inc. (a.k.a. LightPointe Wireless) is privately held. The company was launched in 1998 and is headquartered in San Diego, CA, with regional offices/presence in Europe (Germany & France) and Asia (Thailand). LightPointe also provides solutions via its AirePointe Security & Government Solutions Division (www.AirePointe.com). LightPointe is the number one manufacturer in the world of point-to-point Gigabit Ethernet Free Space Optics and Hybrid Optical-Radio Bridges, and manufactures a complete line of 4G/LTE backhaul radios (60 GHz & 70/80 GHz e-band) for telecom carriers and enterprises such as businesses, schools, the military & government agencies. With over $80 million in product development and over eight key patents, LightPointe has deployed thousands of Gigabit Ethernet bridges and digital video/security backhaul solutions worldwide.

Silicon Wave is a San Diego-based company that specializes in Bluetooth wireless technology. It is recognized as a pioneer in this field and focuses on the design, development, and manufacturing of radio frequency integrated circuits. The company produces RF systems-on-chip that are utilized in various wireless and broadband communication applications. Through its innovative solutions, Silicon Wave contributes significantly to advancements in wireless communication technology.

Silicon Wave is a San Diego-based company that specializes in Bluetooth wireless technology. It is recognized as a pioneer in this field and focuses on the design, development, and manufacturing of radio frequency integrated circuits. The company produces RF systems-on-chip that are utilized in various wireless and broadband communication applications. Through its innovative solutions, Silicon Wave contributes significantly to advancements in wireless communication technology.

Silicon Wave is a San Diego-based company that specializes in Bluetooth wireless technology. It is recognized as a pioneer in this field and focuses on the design, development, and manufacturing of radio frequency integrated circuits. The company produces RF systems-on-chip that are utilized in various wireless and broadband communication applications. Through its innovative solutions, Silicon Wave contributes significantly to advancements in wireless communication technology.